← Back to Search

Q-Factor Intervention for Osteoarthritis

N/A
Waitlist Available
Led By Tanner Thorsen, MS
Research Sponsored by The University of Tennessee, Knoxville
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1 month, 2 month
Awards & highlights

Study Summary

This trial will test if a cycling training program can help people with knee osteoarthritis by reducing pain and improving function.

Eligible Conditions
  • Osteoarthritis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1 month, 2 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1 month, 2 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Knee Abduction Moment - Cycling
Knee Abduction Moment - Gait
Secondary outcome measures
Knee Extension Moment - Cycling
Knee Extension Moment - Gait
Knee Injury and Osteoarthritis Outcome Score
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Q-Factor InterventionExperimental Treatment1 Intervention
Participants will progress through three increasing Q-Factors for each cycling workrate; Q-Factor 1 (Q1, 192mm), Q2 (234mm), Q3 (276mm). After completing bouts of all three Q-Factors for a given workrate, workrate will be increased by 20 Watts and bouts at each Q-Factor will be repeated.

Find a Location

Who is running the clinical trial?

The University of Tennessee, KnoxvilleLead Sponsor
83 Previous Clinical Trials
18,529 Total Patients Enrolled
7 Trials studying Osteoarthritis
263 Patients Enrolled for Osteoarthritis
Tanner Thorsen, MS3.927 ReviewsPrincipal Investigator - University of Tennessee, Knoxville
The University of Tennessee, Knoxville
5Patient Review
This is a competent physician.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~6 spots leftby Apr 2025